German pharmaceutical research company Evotec has acquired US-based drug discovery and development company Aptuit for $300m.
The acquisition will support Evotec’s long-term strategy to become a leader in drug discovery and development.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Biological products provider BioreclamationIVT has acquired biopharmaceutical company Asterand Bioscience.
The acquisition will enable BioreclamationIVT to expand its disease-state biospecimen capabilities.
Both companies involved in the acquisition are based in the US.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData
